metastatic triple-negative breast carcinoma Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (3)
Any (1)

Phase 2 (2)
Unknown (2)

Interventional (3)
Observational (1)

Dana-Farber Cancer Institute (1)
Fudan University (1)
Mayo Clinic (1)
Texas Tech University Health Sciences Center, El Paso (1)

No (4)

No (4)

Adult (18+) (4)

I am/have/had

I am/have/hadliver metastasis

I am/have/hadinvasive breast cancer

I am/have/hadHER2

I am/have/hadanatomic stage iiic breast cancer ajcc v8

I am/have/hadwhole brain radiotherapy

I am/have/hadlocally advanced breast carcinoma

I am/have/hadprognostic stage iiib breast cancer ajcc v8

I am/have/hadmetastatic breast cancer

I am/have/hadmetastatic carcinoma

I am/have/hadalopecia

I am/have/hadneutrophil count

I am/have/hadanticoagulant therapy

I am/have/hadcancer

I am/have/hadbrain metastasis

I am/have/hadmultiple malignancies

I am/have/hadmetastatic triple-negative breast carcinoma

I am/have/hadstage iv breast cancer

I am/have/hadtriple negative breast neoplasms

I am/have/hadcryotherapy

I am/have/hadestrogen

added new label for I am/have/had

I am looking for

I am looking forsacituzumab govitecan

I am looking forkeytruda

I am looking formonoclonal antibodies

I am looking forpyrotinib

I am looking forcopper

I am looking formk-3475

I am looking forimmunostimulant

I am looking forpaclitaxel

I am looking forestrogen

I am looking forprogesterone

I am looking forimmunomodulators

I am looking foratezolizumab

I am looking foreverolimus

I am looking forbisphosphonate

I am looking forcapecitabine

I am looking forpembrolizumab

I am looking foradjuvant

I am looking foranticoagulants

I am looking foririnotecan

I am looking forcorticosteroids

added new label for I am looking for

Advanced Filters

Found 4 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Recruiting

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.

This is a Phase II, open-label, randomized controlled umbrella trial evaluating the efficacy and safety of multiple targeted treatment in patients with metastaticTNBC.

everolimus

triple-negative breast cancer

targeted therapy

pyrotinib

capecitabine

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Observational Study
For Females
Recruiting

Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile

In this study investigators will perform cytokine profiling among patients diagnosed with metastatic triple-negative breast cancer at different time points during the treatment.

triple-negative breast cancer

metastatic breast cancer

multiple malignancies

cancer

breast cancer

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Recruiting

Cryoablation Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

This early phase I trial studies the side effects and feasibility of cryoablation, atezolizumab, and nab-paclitaxel in treating patients with triple negative breast cancer that has spread to nearby tissue or lymph nodes (locally advanced) or has spread to other places in the body (metastatic). Cryosurgery, also known as cryoablation …

anatomic stage iiic breast cancer ajcc v8

locally advanced breast carcinoma

prognostic stage iiib breast cancer ajcc v8

metastatic carcinoma

cancer

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Cardiovascular Diseases
Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

liver metastasis

sacituzumab govitecan

invasive breast cancer

HER2

whole brain radiotherapy

8 views
19 Feb, 2024